Search research articles
Contact Us
Filters
Showing results (171-180 of 284) with videos related to
Page
of 29
Sort By:
Antimicrobial Agents and Chemotherapy
|
March 23, 2026
Multidimensional assessment of in-host fitness costs of echinocandin resistance in the opportunistic fungal pathogen <i>Candida glabrata</i> reveals the niche-specific requirement for <i>FKS1</i> and <i>FKS2</i> during infection and gut colonization
Amir Arastehfar, Farnaz Daneshnia, Hrant Hovhannisyan, et al.
Antimicrobial Agents and Chemotherapy
|
June 17, 2025
Expression of 1,3-β-glucan synthase subunits in <i>Candida glabrata</i> is regulated by the cell cycle and growth conditions and at both transcriptional and post-transcriptional levels
Irene Gonzalez-Jimenez, Mikhail V Keniya, Ariel A Aptekmann, et al.
Antimicrobial Agents and Chemotherapy
|
April 4, 2018
Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway
Ashutosh Singh, Kelley R Healey, Priyanka Yadav, et al.
Antimicrobial Agents and Chemotherapy
|
November 4, 2009
Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media
Maiken Cavling Arendrup, Guillermo Garcia-Effron, Cornelia Lass-Flörl, et al.
Antimicrobial Agents and Chemotherapy
|
May 19, 2010
Comparison of caspofungin MICs by means of EUCAST method EDef 7.1 using two different concentrations of glucose
Juan Luis Rodriguez-Tudela, Alicia Gomez-Lopez, Maiken C Arendrup, et al.
Antimicrobial Agents and Chemotherapy
|
January 20, 2011
Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots
Maiken Cavling Arendrup, Juan-Luis Rodriguez-Tudela, Steven Park, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2018
Significantly Improved Pharmacokinetics Enhances <i>In Vivo</i> Efficacy of APX001 against Echinocandin- and Multidrug-Resistant Candida Isolates in a Mouse Model of Invasive Candidiasis
Yanan Zhao, Min Hee Lee, Padmaja Paderu, et al.
Human Vaccines & Immunotherapeutics
|
January 22, 2024
In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19
Viraj Mane, Rikin Mehta, Nadine Alvarez, et al.
Journal of Clinical Microbiology
|
April 11, 2014
Fungal DNA detected in blood samples of patients who received contaminated methylprednisolone injections reveals increased complexity of causative agents
Yanan Zhao, Emilian Armeanu, Richard DiVerniero, et al.
Vaccine
|
September 6, 2012
Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor
Yoonkyung Do, Arnaud M Didierlaurent, Seongho Ryu, et al.
Page
of 29
Search research articles
Search
Showing results (171-180 of 284) with videos related to
Sort By:
Page
of 29
Antimicrobial Agents and Chemotherapy
|
March 23, 2026
Multidimensional assessment of in-host fitness costs of echinocandin resistance in the opportunistic fungal pathogen <i>Candida glabrata</i> reveals the niche-specific requirement for <i>FKS1</i> and <i>FKS2</i> during infection and gut colonization
Amir Arastehfar, Farnaz Daneshnia, Hrant Hovhannisyan, et al.
Antimicrobial Agents and Chemotherapy
|
June 17, 2025
Expression of 1,3-β-glucan synthase subunits in <i>Candida glabrata</i> is regulated by the cell cycle and growth conditions and at both transcriptional and post-transcriptional levels
Irene Gonzalez-Jimenez, Mikhail V Keniya, Ariel A Aptekmann, et al.
Antimicrobial Agents and Chemotherapy
|
April 4, 2018
Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway
Ashutosh Singh, Kelley R Healey, Priyanka Yadav, et al.
Antimicrobial Agents and Chemotherapy
|
November 4, 2009
Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media
Maiken Cavling Arendrup, Guillermo Garcia-Effron, Cornelia Lass-Flörl, et al.
Antimicrobial Agents and Chemotherapy
|
May 19, 2010
Comparison of caspofungin MICs by means of EUCAST method EDef 7.1 using two different concentrations of glucose
Juan Luis Rodriguez-Tudela, Alicia Gomez-Lopez, Maiken C Arendrup, et al.
Antimicrobial Agents and Chemotherapy
|
January 20, 2011
Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots
Maiken Cavling Arendrup, Juan-Luis Rodriguez-Tudela, Steven Park, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2018
Significantly Improved Pharmacokinetics Enhances <i>In Vivo</i> Efficacy of APX001 against Echinocandin- and Multidrug-Resistant Candida Isolates in a Mouse Model of Invasive Candidiasis
Yanan Zhao, Min Hee Lee, Padmaja Paderu, et al.
Human Vaccines & Immunotherapeutics
|
January 22, 2024
In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19
Viraj Mane, Rikin Mehta, Nadine Alvarez, et al.
Journal of Clinical Microbiology
|
April 11, 2014
Fungal DNA detected in blood samples of patients who received contaminated methylprednisolone injections reveals increased complexity of causative agents
Yanan Zhao, Emilian Armeanu, Richard DiVerniero, et al.
Vaccine
|
September 6, 2012
Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor
Yoonkyung Do, Arnaud M Didierlaurent, Seongho Ryu, et al.
Page
of 29